FMCQF OTC
Fresenius Medical Care AG
1W: +0.0%
1M: -13.3%
3M: -0.0%
YTD: -4.2%
1Y: -13.1%
3Y: +9.2%
5Y: -30.9%
$44.58
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$2.7B
+12.3% ▲
5Y CAGR: -8.7%
Capital Expenditures
$915M
-30.8% ▼
5Y CAGR: -15.2%
Free Cash Flow
$1.8B
+4.6% ▲
5Y CAGR: -3.8%
Dividends Paid
$422M
-21.0% ▼
Buybacks
$585M
+0.0% ▲
Net Change in Cash
$559M
+331.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $1.2B | $895M | $732M | $741M | $978M |
| Depreciation & Amort. | $1.6B | $1.8B | $1.8B | $1.7B | $1.5B |
| Stock-Based Comp. | $28M | -$6M | $33M | $0 | $0 |
| Change in Working Capital | -$354M | -$566M | $561M | $444M | $138M |
| Other Non-Cash Items | $1.6B | $47M | -$327M | -$469M | $128M |
| Operating Cash Flow | $2.5B | $2.2B | $2.6B | $2.4B | $2.7B |
| — Investing Activities — | |||||
| Capital Expenditures | -$1.7B | -$1.4B | -$685M | -$699M | -$920M |
| Acquisitions (Net) | -$382M | $1M | $137M | $607M | $232M |
| Investment Purchases | -$129M | -$106M | -$102M | -$82M | -$89M |
| Investment Sales | $144M | $58M | $90M | $75M | $83M |
| Other Investing | $853M | $723M | $16M | $14M | $0 |
| Investing Cash Flow | -$1.2B | -$735M | -$544M | -$85M | -$693M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$359M | -$1.0B | -$1.2B | -$1.9B | $798M |
| Stock Repurchased | -$7M | -$20M | $0 | $0 | -$585M |
| Dividends Paid | -$392M | -$396M | -$329M | -$349M | -$422M |
| Other Financing | -$273M | -$199M | -$340M | -$315M | -$1.2B |
| Financing Cash Flow | -$1.0B | -$1.6B | -$1.9B | -$2.6B | -$1.4B |
| Net Change in Cash | $400M | -$208M | $153M | -$242M | $559M |
| Cash End of Period | $1.5B | $1.3B | $1.4B | $1.2B | $1.6B |
| Free Cash Flow | $806M | $756M | $1.9B | $1.7B | $1.8B |